Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
Ejhaem|December 1, 2025
Baseline Cytomegalovirus Immunoglobulin G Levels Predict Reactivation in Patients With Multiple Myeloma Receiving ElranatamabUkyo Kondo, Taku Kikuchi, Shotaro Sugita, et al.
Hematological Oncology|August 3, 2024
Prognostic value of the "dynamic" R2-ISS in patients with multiple myeloma undergoing anti-CD38 antibody-based triplet therapiesTaku Kikuchi, Yuki Oda, Ukyo Kondo, et al.
International Journal of Hematology|December 3, 2025
Outcomes of elranatamab in relapsed/refractory multiple myeloma: prognostic impact of monocyte count, MyCARe, and R2-ISSTaku Kikuchi, Shotaro Sugita, Ukyo Kondo, et al.
Gut and Liver|May 10, 2012
Role of enhanced visibility in evaluating polyposis syndromes using a newly developed contrast image capsule endoscopeKen Hatogai, Naoki Hosoe, Hiroyuki Imaeda, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 21, 2025
Cytomegalovirus Retinitis During Idecabtagene Vicleucel Therapy in Patients With Relapsed/Refractory Multiple MyelomaTaku Kikuchi, Miyu Watanabe, Nobuhiro Tsukada, et al.
Annals of Hematology|August 25, 2021
Minimal residual disease detection in multiple myeloma: comparison between BML single-tube 10-color multiparameter flow cytometry and EuroFlow multiparameter flow cytometryKota Sato, Kiyoshi Okazuka, Tadao Ishida, et al.
Annals of Hematology|November 26, 2008
Myeloablative unrelated cord blood transplantation for acute leukemia patients between 50 and 55 years of age: single institutional retrospective comparison with patients younger than 50 years of ageTakaaki Konuma, Satoshi Takahashi, Jun Ooi, et al.
Hepatology International|October 25, 2011
Disadvantages of peginterferon and ribavirin treatment in older patients with chronic hepatitis C: an analysis using the propensity scoreHirotoshi Ebinuma, Hidetsugu Saito, Shinichiro Tada, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|July 9, 2011
[Advanced gallbladder cancer that showed complete response to gemcitabine plus S-1 chemotherapy]Maiko Takita, Eisuke Iwasaki, Ken Hatogai, et al.
Transplantation and Cellular Therapy|November 14, 2021
Retrospective Analysis of Autologous Stem Cell Transplantation for AL Amyloidosis: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell TransplantationShin-Ichi Fuchida, Koji Kawamura, Kazutaka Sunami, et al.
Pageof 13